Pamukcu Rifat - Insider Non-Derivative Transactions at Aprea Therapeutics, Inc. (APRE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 20, 2024, Pamukcu Rifat's relationship to Aprea Therapeutics, Inc. (APRE) is Director, and currently has 4,401 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other APRE insiders.
Data Source: SEC.
Pamukcu Rifat - Insider Non-Derivative Transactions of APRE Common Stock
Pamukcu Rifat - Insider Non-Derivative Transactions at APRE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 21, 2024 | Acquisition -- (Common Stock) | 1045 | 0 | 4401 |
| Aug 24, 2023 | Acquisition -- (Common Stock) | 500 | 0 | 3356 |
| Aug 24, 2022 | C -- (Common Stock) | 271870 | 0 | 14108 |
| Aug 24, 2022 | C -- (Common Stock) | 49280 | 0 | 57142 |